Maravai LifeSciences Holdings Inc reports results for the quarter ended in December - Earnings Summary

Maravai Lifesciences Holdings

22/02/2023 22:02

* Maravai LifeSciences Holdings Inc  MRVI.OQ  reported
quarterly
adjusted earnings of 35 cents​​ per share for the quarter ended
in December. The mean expectation of twelve analysts for the
quarter was for earnings of 34 cents per share.
    * Revenue fell 10.4% to $204.71 million from a year ago;
analysts
expected $204.93 million. 
    * Maravai LifeSciences Holdings Inc's reported EPS for the
quarter
was 28 cents​.
    * The mean earnings estimate of analysts had risen by
about 0.8%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Maravai LifeSciences Holdings Inc shares had fallen
by 2.2% this
quarter.
    * The company reported quarterly net income of $37.63
million.
    * Wall Street's median 12-month price target for Maravai
LifeSciences Holdings Inc is $25.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
22 at 10:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      0.34           0.35           Beat
 Sep. 30 2022      0.33           0.37           Beat
 Jun. 30 2022      0.45           0.54           Beat
 Mar. 31 2022      0.44           0.54           Beat